Furthermore, analyses of microarrays datasets derived from 4 independent cohorts of PD patients led to the identification of aberrant osteopontin (SPP1) signaling and increased expression of CREB-binding protein as consistent markers associated with the progression of aSyn pathology in the rodent model and in PD brains. The gene discussed is CREBBP; the disease is Parkinson disease.